FDA Grants Traditional Approval to Tarlatamab-dlle for Extensive Stage Small Cell Lung Cancer By Ogkologos - January 22, 2026 413 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the DeLLphi-304 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Announces 2026 Society Award Recipients Honouring Excellence in Cancer Research, Care and Leadership Adjuvant Olaparib Continues to Improve Multiple Outcomes in Patients with Germline BRCA1/2-associated High-Risk HER2-negative EBC EMA Recommends Refusing the Marketing Authorisation for Copper (64Cu) Oxodotreotide MOST POPULAR Addressing Common Sexual Health Concerns During Cancer Survivorship: An Expert Perspective January 17, 2023 Woman with Nonverbal Autism Diagnosed with Breast Cancer After Caregiver Sister... October 30, 2020 At 27, She Was Told She Was Too Young For Breast... February 6, 2020 Rucaparib Extends PFS in the Maintenance Treatment of Recurrent EOC Without... September 1, 2020 Load more HOT NEWS EMA Recommends Extension of Therapeutic Indications for Cetuximab 10 Ways the Inflation Reduction Act will Impact Cancer Care At 27, She Was Told She Was Too Young For Breast... Insights Into the Biology of Response and Resistance to MAPK Pathway...
